HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudio Gasperini Selected Research

Claudio Gasperini Research Topics

Disease

58Multiple Sclerosis
11/2022 - 01/2002
18Relapsing-Remitting Multiple Sclerosis
02/2022 - 11/2003
5Inflammation (Inflammations)
01/2020 - 06/2003
3Disease Progression
08/2021 - 01/2020
3Atrophy
01/2021 - 11/2013
2Infections
06/2022 - 11/2020
2Progressive Multifocal Leukoencephalopathy
02/2022 - 11/2015
2Fatigue
03/2020 - 01/2019
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017 - 10/2015
2Autoimmune Diseases (Autoimmune Disease)
10/2015 - 10/2005
1Dementia (Dementias)
07/2022
1Parkinsonian Disorders (Parkinsonism)
07/2022
1Chronic Progressive Multiple Sclerosis
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Demyelinating Diseases (Demyelinating Disease)
08/2021
1Lymphopenia (Lymphocytopenia)
06/2021
1Anterograde Amnesia
01/2021
1Neck Pain (Cervicalgia)
01/2021
1Psychomotor Agitation (Akathisia)
01/2021
1Brain Diseases (Brain Disorder)
01/2021
1Cortical Blindness (Anton Syndrome)
01/2021
1Vertigo (Positional Vertigo)
01/2021
1Unconsciousness (Loss of Consciousness)
01/2021
1Virus Diseases (Viral Diseases)
06/2019
1Cognitive Dysfunction
01/2019
1Necrosis
01/2019
1Neutropenia
09/2018
1Vascular Diseases (Vascular Disease)
01/2018
1Ganglion Cysts (Ganglion)
02/2015
1Hypoxia (Hypoxemia)
07/2014
1Chronic Disease (Chronic Diseases)
12/2011

Drug/Important Bio-Agent (IBA)

8Interferon-betaIBA
01/2014 - 01/2002
6Natalizumab (Tysabri)FDA Link
11/2022 - 01/2012
5InterferonsIBA
07/2016 - 06/2002
4Pharmaceutical PreparationsIBA
08/2021 - 06/2003
4Dimethyl FumarateIBA
06/2021 - 01/2014
4CytokinesIBA
01/2020 - 03/2014
4Fingolimod Hydrochloride (FTY720)FDA Link
10/2018 - 01/2012
4AntibodiesIBA
01/2014 - 06/2003
3nitazoxanide (NTZ)FDA Link
02/2022 - 11/2015
3nabiximols (Sativex)IBA
01/2022 - 01/2017
3Messenger RNA (mRNA)IBA
01/2022 - 01/2014
34-Aminopyridine (4 Aminopyridine)FDA Link
01/2021 - 01/2019
3Glatiramer Acetate (Copaxone)FDA Link
11/2020 - 01/2012
3Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2006
2VaccinesIBA
01/2022 - 11/2021
2Dronabinol (THC)FDA LinkGeneric
10/2020 - 01/2020
2CannabidiolIBA
10/2020 - 01/2020
2Immunoglobulin G (IgG)IBA
05/2017 - 10/2005
2Interleukin-17 (Interleukin 17)IBA
08/2015 - 03/2014
2Lactic Acid (Lactate)FDA LinkGeneric
02/2015 - 07/2014
2Adrenal Cortex Hormones (Corticosteroids)IBA
02/2013 - 01/2002
2Neutralizing AntibodiesIBA
10/2009 - 01/2002
1Levodopa (L Dopa)FDA LinkGeneric
07/2022
1CannabinoidsIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1siponimodIBA
01/2022
1teriflunomideIBA
08/2021
1Influenza Vaccines (Influenza Vaccine)FDA Link
04/2021
1ocrelizumabIBA
04/2021
1OzoneIBA
01/2021
1LipidsIBA
01/2020
1lipoxin B4IBA
01/2020
1lipoxin A4IBA
01/2020
1EicosanoidsIBA
01/2020
1RNA (Ribonucleic Acid)IBA
06/2019
1resiquimodIBA
06/2019
1InterleukinsIBA
01/2019
1Interleukin-2 (IL2)IBA
01/2019
1Alemtuzumab (Campath)FDA Link
09/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1AcetylcholinesteraseIBA
01/2018
1ButyrylcholinesteraseIBA
01/2018
1Myelin-Oligodendrocyte GlycoproteinIBA
01/2018
1anti-aquaporin 4 autoantibodyIBA
01/2018
1opicinumabIBA
11/2017
1Monoclonal AntibodiesIBA
11/2017
1Purinergic P2X7 ReceptorsIBA
01/2017
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2016
1p38 Mitogen-Activated Protein KinasesIBA
10/2015
1Retinaldehyde (Retinal)IBA
02/2015
1Interleukin-8 (Interleukin 8)IBA
03/2014
1ChemokinesIBA
03/2014
1Interleukin-6 (Interleukin 6)IBA
03/2014
1Biological ProductsIBA
01/2014
1Staphylococcal Protein A (Protein A)IBA
01/2014
1Neuroprotective AgentsIBA
11/2013
1laquinimodIBA
11/2013
1anandamide (arachidonylethanolamide)IBA
05/2013
1AntigensIBA
01/2013
1Human Serum AlbuminFDA LinkGeneric
01/2012
1Bovine Serum AlbuminIBA
01/2012
1Immunologic Factors (Immunomodulators)IBA
01/2012
1TabletsIBA
09/2010
1CladribineFDA LinkGeneric
09/2010
1Interferon beta-1aFDA Link
07/2010

Therapy/Procedure

17Therapeutics
10/2022 - 03/2006
5Injections
01/2022 - 02/2017
1Ligation
03/2014
1Parenteral Infusions
12/2011